There’s a more accurate way of measuring who’s at risk for cholesterol-related health issues. So why don’t more doctors use ...

Pregnant woman holding her belly. The first and only at-home blood test that predicts a pregnant person’s risk of developing preeclampsia has launched. Known as Encompass, the test from Mirvie can ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data generated by researchers at Mayo Clinic will be ...

Finger-prick blood test alongside online thinking test could flag people with early memory problems which could become ...

You’re at an end-of-year holiday family gathering and instead of talking politics and religion, everyone is sharing stories about family members. That's when you find out for the first time that the ...

Penn researchers are developing a blood test to predict kidney disease risk in Black Americans, who face disproportionately ...

Cascade genetic risk evaluation in families with hereditary cancer can reduce the burden of disease but the rate of germline genetic testing in relatives of patients at risk is low. We identified all ...

The Breast Cancer Risk Assessment Tool is an interactive calculator that estimates a woman’s risk of developing breast cancer Vanessa Etienne is a Staff Writer for PEOPLE on the Health team. She ...

If you have a family history of cancer, your doctor may recommend genetic testing to help understand your potential risk. These DNA tests examine if someone has inherited an increased risk of cancer.

For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

DNA testing to predict disease risk has the potential to prevent disease and save lives. Yet few Australians can currently access predictive DNA testing via the health-care system. That may soon ...

Over the last several years, federal concern about genetic testing has been steadily growing. Regulators have watched Medicare Part B spending on molecular and genetic tests spike while a relatively ...